ono 1078 has been researched along with Lung Diseases, Interstitial in 2 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chohnabayashi, N | 1 |
Sugiura, R | 1 |
Nishimura, N | 1 |
Takahashi, N | 1 |
Iwanaga, T | 1 |
Aizawa, H | 1 |
Koto, H | 1 |
Watanabe, K | 1 |
Kishikawa, R | 1 |
Ikeda, T | 1 |
Shoji, S | 1 |
Nishima, S | 1 |
Hara, N | 1 |
1 review available for ono 1078 and Lung Diseases, Interstitial
Article | Year |
---|---|
[Adverse effects of leukotriene-antagonists].
Topics: Acetates; Anaphylaxis; Chemical and Drug Induced Liver Injury; Chromones; Cyclopropanes; Drug Intera | 2007 |
1 other study available for ono 1078 and Lung Diseases, Interstitial
Article | Year |
---|---|
Acute interstitial pneumonia induced by ONO-1078 (pranlukast), a leukotriene receptor antagonist.
Topics: Acute Disease; Anti-Asthmatic Agents; Asthma; Chromones; Diagnosis, Differential; Female; Humans; Le | 2001 |